Comparative Evaluation of Topical 10% Potassium Hydroxide and Intralesional MMR Vaccine in Pediatric Molluscum Contagiosum: A Prospective Interventional Study
Article Information
Publication Timeline
- Received28 March 2026
- Accepted29 April 2026
- Published
Abstract
Background: The infection called Molluscum contagiosum (MC) is caused by a virus called a poxvirus and is characterized by small dome-shaped bumps on a child’s skin. MC is often treated with various treatments (some have been around for a long time) however, the best possible options will be safe, effective, easy to apply and tolerated well by children. This study was performed to compare the efficacy and safety of the use of topical 10% Potassium Hydrate (KOH) to the use of intralesional measles, mumps and rubella (MMR) vaccination when using those two treatments for caregivers who have a child with Molluscum contagiosum.
Methods: This prospective study was conducted on 60 children (1-12 years old) with clinically diagnosed molluscum contagiosum and randomly assigned them to two groups of 30. Group A had topical 10% KOH applied, while Group B was treated using intralesional MMR vaccine. Following up for two years, including six months after treatment, the researchers assessed and compared the two groups on treatment response, lesion clearance rate, recurrence rate, and adverse effects associated with the respective treatments.
Results: A complete clearance of the lesions occurred in 86.7% of the patients who received the MMR treatment; however, only 70% had total lesion clearance in the KOH group (p<.05). All MMR-treated lesions will resolve within an average of four weeks; however, many KOH-receiving lesions will have a longer resolution time. Patients who had an intralesional injection of MMR had fewer adverse events (pain, redness, hyperpigmentation) compared to KOH-treated patients. Additionally, patients who received intralesional injection of MMR had fewer instances of recurrence of the lesion.
Conclusion: The use of the MMR vaccine injected under the skin has been proven to be a better treatment than using a topical solution of (potassium hydroxide) KOH 10%, and is therefore considered superior. There is evidence that the MMR vaccine will clear more molluscum faster, have less reoccurrence, and be better tolerated than topical treatments, thereby supporting its use in patients who have multiple lesions or who have not responded to previous treatments.
References
- Hanson D, Diven DG. Molluscum contagiosum. Dermatol Online J. 2003;9(2):2. [Google Scholar][Crossref]
- Olsen JR, Gallacher J, Piguet V, Francis NA. Epidemiology of molluscum contagiosum in children: a systematic review. Fam Pract. 2014;31(2):130–136. [Google Scholar][Crossref]
- Berger EM, Orlow SJ, Patel RR, Schaffer JV. Experience with molluscum contagiosum and associated inflammatory reactions in a pediatric dermatology practice: the bump that rashes. Arch Dermatol. 2012;148(11):1257–1264. [Google Scholar][Crossref]
- Brown J, Janniger CK, Schwartz RA, Silverberg NB. Childhood molluscum contagiosum. Int J Dermatol. 2006;45(2):93–99. [Google Scholar][Crossref]
- van der Wouden JC, van der Sande R, Kruithof EJ, Sollie A, van Suijlekom-Smit L, Koning S. Interventions for cutaneous molluscum contagiosum. Cochrane Database Syst Rev. 2017;5:CD004767. [Google Scholar][Crossref]
- Silverberg NB. Pediatric molluscum contagiosum: optimal treatment strategies. Paediatr Drugs. 2003;5(8):505–512. [Google Scholar][Crossref]
- Romiti R, Ribeiro AP, Grinblat BM, Rivitti EA, Romiti N. Treatment of molluscum contagiosum with potassium hydroxide: a clinical approach in 35 children. Pediatr Dermatol. 1999;16(3):228–230. [Google Scholar][Crossref]
- Nofal A, Nofal E. Intralesional immunotherapy of molluscum contagiosum: a new perspective. J Am Acad Dermatol. 2009;60(5):901–902. [Google Scholar][Crossref]
- Rajouria EA, Amatya A, Karn D. Comparative study of 5% potassium hydroxide solution versus 0.05% tretinoin International Journal of Medical and All Body Health Research www.allmedicaljournal.com cream for molluscum contagiosum in children. Kathmandu Univ Med J. 2011;9(36):291–294. [Google Scholar][Crossref]
- Handjani F, Behazin E, Sadati MS. Comparison of 10% potassium hydroxide solution versus cryotherapy in the treatment of molluscum contagiosum: an open randomized clinical trial. J Dermatolog Treat. 2014;25(3):249–250. [Google Scholar][Crossref]
- Metkar A, Pande S, Khopkar U. An open, nonrandomized comparative study of imiquimod 5% cream versus 10% KOH solution in the treatment of molluscum contagiosum. Indian J Dermatol Venereol Leprol. 2008;74(6):614–618. [Google Scholar][Crossref]
- Chauhan PS, Mahajan VK, Mehta KS, Rawat R. The efficacy and tolerability of intralesional measles-mumps-rubella (MMR) vaccine in the treatment of molluscum contagiosum. Indian Dermatol Online J. 2015;6(3):164–169. [Google Scholar][Crossref]
- Ahmed I, Agarwal S, Ilchyshyn A, Charles-Holmes S, Berth-Jones J. Liquid nitrogen cryotherapy of common warts: cryo-spray vs. cotton wool bud. Br J Dermatol. 2001;144(5):1006–1009. [Google Scholar][Crossref]
- Mahajan BB, Naik H. Intralesional immunotherapy with killed Mycobacterium w vaccine versus intralesional candida antigen for the treatment of molluscum contagiosum: a comparative study. J Cutan Aesthet Surg. 2016;9(2):99–103. [Google Scholar][Crossref]
- Theos AU, Cummins R, Silverberg NB, Paller AS. Effectiveness of imiquimod cream 5% for treating childhood molluscum contagiosum in a double-blind, randomized pilot trial. Cutis. 2004;74(2):134–138, 141– 142. [Google Scholar][Crossref]
How to Cite
Sharma, S., Saxena, D., Noor, J., Danish, M., & Bharti, A. (2026). Comparative Evaluation of Topical 10% Potassium Hydroxide and Intralesional MMR Vaccine in Pediatric Molluscum Contagiosum: A Prospective Interventional Study. International Journal of Medical and All Body Health Research, 7(2), 242-246. https://doi.org/10.54660/IJMBHR.2026.7.2.242-246
Sharma, Shantanu, et al. "Comparative Evaluation of Topical 10% Potassium Hydroxide and Intralesional MMR Vaccine in Pediatric Molluscum Contagiosum: A Prospective Interventional Study." International Journal of Medical and All Body Health Research, vol. 7, no. 2, 2026, pp. 242-246. https://doi.org/10.54660/IJMBHR.2026.7.2.242-246.
Sharma, S., Saxena, D., Noor, J., Danish, M. and Bharti, A. (2026) 'Comparative Evaluation of Topical 10% Potassium Hydroxide and Intralesional MMR Vaccine in Pediatric Molluscum Contagiosum: A Prospective Interventional Study', International Journal of Medical and All Body Health Research, 7(2), pp. 242-246. doi: 10.54660/IJMBHR.2026.7.2.242-246.
Sharma S, Saxena D, Noor J, Danish M, Bharti A. Comparative Evaluation of Topical 10% Potassium Hydroxide and Intralesional MMR Vaccine in Pediatric Molluscum Contagiosum: A Prospective Interventional Study. International Journal of Medical and All Body Health Research. 2026;7(2):242-246. doi:10.54660/IJMBHR.2026.7.2.242-246
Similar Articles
- Nursing Assessment of Constipation's Risk Factors in Patients with Coronary Artery Disease Vol 7, Issue 2 (2026)
- The Incidence and Pattern of Congenital Heart Disease Among Infants of Diabetic Mothers Vol 7, Issue 2 (2026)
- Psychological Barriers to Natural Delivery: How Childbirth Anxiety Shapes Mode of Delivery and Hospital Preferences Among Najaf Women Vol 7, Issue 2 (2026)
- Barriers to the Introduction of Kangaroo Mother Care by Nurses and Midwives at Hospitals of Kirkuk City Vol 7, Issue 2 (2026)
- Post-COVID-19 Olfactory Disorders: Diagnosis, Prognosis, and Treatment Strategies Vol 7, Issue 2 (2026)
Find this Article on
Google Scholar Semantic Scholar OpenAlex Scilit Crossref ResearchGate BASEA newly published article may take a few days to appear on these services.